Education Posters Resources General Info Supporters

Registration Options

Activity Date: 04/17/2016

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Attention-deficit/ hyperactivity disorder (ADHD) is the most commonly diagnosed childhood disorder. Between 1995 and 2008, stimulants prescribed to treat ADHD increased six-fold among adults in the United States. While these medications are the most effective pharmacotherapy treatment for ADHD, there are risks and cautions associated with use. 

Pharmaceutical stimulants, similar to illicit psychostimulants, have the potential to induce abuse and dependence. This session will address the increase in reports related to stimulant misuse, abuse, and diversion within ADHD.

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Attend and participate in the entire session and reflect upon its teachings.
  • Complete the evaluation at the end of the activity. (sign in first)
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

This course will be provided at the CPNP 2016 Annual Meeting, April 17-20, 2016. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Compare the prevalence of stimulant abuse, misuse, and nonmedical use in patients with attention-deficit/hyperactivity disorder and the general population.
  2. Select medication for the treatment of attention-deficit/ hyperactivity disorder with a lower risk of nonmedical use.
  3. Construct a treatment plan to monitor patients with attention-deficit/hyperactivity disorder for misuse of stimulant medications.

Continuing Education Credit and Disclosures

Activity Date: 04/17/2016
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-16-004-L01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.1 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-16-004-L01-P (1.0 contact hours).